Jyothy Labs (532926) Q4 15/16 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 15/16 earnings summary
16 Oct, 2026Executive summary
FY16 consolidated net sales rose 9.3% YoY to ₹1,644.73 crore; operating EBITDA increased 24% to ₹237.6 crore and PAT grew 30.4% to ₹157.95 crore.
Powerbrands generated 86.9% of revenue and grew sales 10.3%; volume growth was 9.3%.
Growth came amid subdued rural demand linked to deficient rainfall; lower oil prices and manufacturing automation helped offset input-cost and operating pressures.
Financial highlights
Consolidated net sales were ₹1,644.73 crore, up 9.26% YoY; standalone net sales were ₹1,573.51 crore versus ₹1,428.27 crore.
Consolidated EBITDA rose to ₹230.35 crore from ₹168.64 crore; PBT was ₹197.26 crore and PAT ₹157.96 crore, up 30.4% YoY.
Standalone PBT increased 37.1% to ₹201.41 crore; PAT was ₹162.36 crore versus ₹142.79 crore, and basic EPS was ₹8.97 versus ₹7.89.
Consolidated gross sales, including excise duty, reached ₹1,660.85 crore, up 9.56% YoY; sales growth was reported across South and non-South markets.
Consolidated operating cash flow was ₹191.47 crore; cash and cash equivalents at year-end were ₹106.?? crore?
Outlook and guidance
Growth priorities include rural-market penetration, wider distribution, targeted communication, product innovation and relevant extensions such as Pril dishwash bar and Ujala detergent powder.
Management expected rural consumption to turn around based on the 2016 monsoon forecast; smaller towns, premiumisation and distribution expansion were identified as growth opportunities.
SAP S/4HANA was planned to cover critical business processes and was expected to become operational from April 2017.
Latest events from Jyothy Labs
- Revenue grew, but inflation compressed margins and profit despite market-share gains.532926
Q4 21/22 - FY24 growth and margin gains offset a subdued, competitive FMCG backdrop.532926
Q4 23/24 - Revenue and EBITDA grew despite lockdowns, with a ₹23.5 crore excise-refund charge.532926
Q4 20/21 - Lockdown-hit FY20 results met with a pivot to hygiene, value packs and digital reach.532926
Q4 19/20 - Sales and PAT grew as margins held despite input-cost pressure.532926
Q4 18/19 - Revenue and profit surged as margins recovered, with Fabric Care leading growth.532926
Q4 22/23 - GST recovery lifted comparable sales, while prior-year tax benefits weighed on PAT.532926
Q4 17/18 - PAT rose 176.6%; FY2017-18 revenue growth target set at 12%.532926
Q4 16/17 - Merger-led sales expansion met integration costs and acquired-brand amortization pressure.532926
Q4 12/13